期刊文献+

三七对糖尿病肾病大鼠保护作用的观察 被引量:6

Protective effect of Panax notoginseng on kidney disease in diabetic rats
原文传递
导出
摘要 目的观察三七对糖尿病肾病(DN)大鼠的治疗效果,探讨其作用机制,为糖尿病及DN的预防及治疗提供参考。方法予不同剂量三七治疗8周,观察其对STZ诱导的DN大鼠肾脏功能及结构的影响,观察各组血脂、血糖、体重、24h尿蛋白定量、肾脏VEGF表达水平。结果不同三七剂量组血糖、TG、尿量、24h尿蛋白定量及VEGF表达均有不同程度降低(P<0.05或P<0.01),而体重、HDL-C均有不同程度增加(P<0.05或P<0.01)。结论三七治疗DN大鼠有一定疗效,其机制可能与改善相关代谢异常及改善组织缺血有关。 Objective To investigate the effect of panax notoginseng on experimental diabetic nephropathy (DN)and its mechanism to provide reference for the treatment of diabetes and its microcomplieations. Methods Diabetes was induced by STZ in rats. They were treated with panax notoginseng preparations for 8 weeks. After treatment, the effect of panax notoginseng preparations on functions and structures of kidney was observed, and the lipid and glucose levels in plasma, body weight, the 24 h urinary protein excretion, and the expression of vascular endothelial growth factor(VEGF)of diabetic rats were determined for analysis. Results With different doses of panax notoginseng, the glucose and triglycerides (TG)levels, urine volume, 24 h urinary protein excretion, and expression of VEGF of diabetic rats were all decreased (P〈0.05 or P〈0.01),while the body weight and high-density lipoprotein cholesterol( HDL-C) were increased(P〈0. 05 or P〈0. 01). The kidney structures and functions of diabetic rats were improved. Conclusion Panax notoginseng is effective for DN. The possible mechanism may be related to the correction of the related metabolic disorders and improvement of ischemic state of the renal tissues.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第10期931-934,共4页 Chinese Journal of Diabetes
基金 2011年联邦中青年医药师基金项目(2011-LB-08)
关键词 糖尿病微血管病变 糖尿病肾病 三七 血管内皮生长因子 大鼠 Diabetic microangiopathy Diabetic nephropathy(DN) Panax notoginseng Vascular endothelial growth factor(VEGF) Rats
  • 相关文献

参考文献10

  • 1American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care, 2009, 32(Suppl 1).-$13-$61.
  • 2Lewis A, Steadman R, Manley P, et al. Diabetic nephropa- thy, inflammation, hyaluronan and interstitial fibrosis. Histol histopathol, 2008, 23= 731-739.
  • 3Amin KA, Awad EM, Nagy MA. E{{ects o{ panax quinque{o lium on streptozotocin-induced diabetic rats:role of Cpeptide, nitric oxide and oxidative stress. Int J Clin Exp Med, 2011, 4 136-147.
  • 4Xu M, Dai DZ, Dai Y, et al. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual en- dothelin receptor antagonist CPU0213 in rats. Am J Nephrol, 2009, 29:252-256.
  • 5Kim NH, Oh JH, Seo JA, et al. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 indiabetic nephropathy. Kindey Int, 2005, 67:167-177.
  • 6殷培,袁伟杰,叶志斌,于光,张国兆,于建平,崔若兰.低密度脂蛋白对大鼠系膜细胞产生血管内皮生长因子的影响[J].中华肾脏病杂志,2003,19(5):324-325. 被引量:7
  • 7王素明,陈梅,杨宏伟,张玲慧.2型糖尿病患者血清脂联素水平及其与相关并发症的关系[J].现代中西医结合杂志,2011,20(10):1285-1286. 被引量:5
  • 8Lee EY, (;hung CH, Kim JH, et al. Antioxidants amelioate the expression of Vascular endothelial growth factor mediated by protein kinase C in diabetic podocytcs. Nephrol Dial Trans plant, 2006, 21:1496-1503.
  • 9江苏新医学院.中药大词典.上海:上海科学技术出版社,2001:586.
  • 10傅珍春,徐刚,葛婷爱,江婷婷,袁赤亭.三七总皂苷对糖尿病大鼠肾脏结缔组织生长因子表达的影响[J].中华中医药学刊,2008,26(5):1042-1045. 被引量:6

二级参考文献38

  • 1于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 2李忠亮,常冰玲.血塞通治疗糖尿病肾病的疗效观察[J].中国误诊学杂志,2005,5(11):2031-2032. 被引量:13
  • 3王书畅,王战建,王振贤.不同糖耐量人群脂联素基因多态性与胰岛素抵抗的关系[J].临床荟萃,2007,22(5):318-321. 被引量:7
  • 4[1]Sato TN,Tozawa Y,Deutsch U,et al.Distinct roles of the receptor tyrosin kinases Tie-1 and Tie-2 in blood vessel formation[J].Natru,1995,376:70-74.
  • 5[3]Mogensen CE,Anderson MJ.Increased kidney size and glomerular filtration rate in untreated juvenile diabetes:normalization by insulin-treatment[J].Diabetologia,1975,11(3):221-224.
  • 6[4]Seyer-Hansen K.Renal hypertrophy in streptozotocin-diabetic rats[J].Clin Sci Mol Med Suppl,1976,51(6):551-555.
  • 7[5]Schmitz A,Gundersen HJ,Osterby R.Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus.Lack of glomerular hypertrophy[J].Diabetes,1988,37(1):38-43.
  • 8[6]Baumgartl HJ,Sigl G,Banholzer P,et al.On the prognosis of IDDM patients with large kidneys[J].Nephrol Dial Transplant,1998,13(3):630-634.
  • 9[7]Bradham DM,Igarashi A,Potter RL,et al.Connective tissue growth factor:a cysteine-rich mitogen secreted by human vascuclar endothelial cells is related to the SRC-induced immediate early gene product CEF-10[J].J Cell Biol,1991,114(6):1285-1294.
  • 10[8]Oemar BS,Luscher TF.Connective tissue growth factor,friend or foe[J].Arterioscler Thromb Vasc Biol,1997,17(8):1483-1489.

共引文献15

同被引文献203

引证文献6

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部